Biography
Main responsibilities
Phil is General Counsel of Aviva Investors and is a member of the Aviva Investors Executive Committee. He is responsible for leading the global legal function across all sectors and locations.
Experience and qualifications
Phil was appointed as General Counsel of Aviva Investors in July 2018, leading a global function of over 70 staff and is a member of both the Aviva Investors Executive team and the Aviva plc General Counsel’s Legal Executive. Prior to assuming the General Counsel role, he headed up the UK Legal Trading team and overseas legal teams in Aviva Investors France, Poland, Singapore and the U.S. Phil has over twenty years’ experience and, before joining Aviva Investors, worked at BNY Mellon Asset Management and Newedge UK. Phil has also worked for leading law firms in London and Sydney. Phil has a degree in Law from the University of Liverpool and is currently studying for an Executive MBA.
Related profiles

Steven Blackie
Global Head of Product
View profile

Nathan Adams
People Director
View profile

Kate McClellan
Chief Operating Officer
View profile

Daniel McHugh
Chief Investment Officer, Real Assets
View profile

Steve Farrall
Chief Risk Officer
View profile

Mark Versey
Chief Executive Officer
View profile

Louise Kay
Global Head of Client Solutions
View profile

Colin Purdie
Chief Investment Officer, Liquid Markets
View profile

Tom Howard
Chief Financial Officer
View profile
We know what it takes to make a difference
It takes working together to drive sustainable transition across People, Climate, and Earth. It takes Aviva Investors.

You might also be interested in

Investing in a just transition to net zero: A Q&A with Nick Robins
30 Jun 2022
Reaching net zero by 2050 will require significant injections of capital. But it is also an opportunity to rethink social relationships, as Professor Nick Robins explains.
Read more

Supply chains, painkillers and gene editing: ESG risks in pharma
29 Jun 2022
Reflecting on ESG risks in the pharmaceutical industry, Sora Utzinger discusses supply chains and counterfeit medicines, access to painkillers, and the ethics of gene editing.
Read more

What does the data say? Biodiversity loss: From horror to hope
24 Jun 2022
In this month’s instalment of our visual series on topical themes, we explore the world of biodiversity.
Read more

ESG investing: Lasting lessons from Russia’s war on Ukraine
23 Jun 2022
Russia’s invasion of Ukraine has led to ESG receiving widespread flak. While much of the criticism is unjustified, the episode underlines how many issues related to ESG are complex and involve trade-offs. Investment approaches may need fine tuning, especially if the geopolitical landscape continues to change so rapidly.
Read more

UK Equities: Five questions with Charlotte Meyrick and Trevor Green
14 Jun 2022
Charlotte Meyrick and Trevor Green explain why 2022 has all been about getting your sector calls right in UK equities.
Read more

Inflation, volatility and default risk: The outlook for high yield
13 Jun 2022
The co-heads of our global high yield team explain how the asset class is standing up to current headwinds.
Read more

Antimicrobial resistance: Q&A with Dame Sally Davies
10 Jun 2022
Resistance to antibiotics is already killing millions. Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, spoke to AIQ on the latest developments to counter antimicrobial resistance Antimicrobial Resistance (AMR) in the UK and globally.
Read more

The AIQ Podcast: Investing towards a new social contract
9 Jun 2022
As life returns to some form of normality, governments are free to move their focus from COVID-19 to left-behind communities and delivering a just transition. This is important to secure long-term economic outcomes, but also comes with investment opportunities and risks.
Read more

Deep water: Ten threats to marine ecosystems
8 Jun 2022
Our air, weather, food, the health of diverse marine life and millions of jobs all depend on the ocean. But we have not done well as custodians of marine ecosystems. Here, we set out ten ways where human actions threaten the health of an essential environment.
Read more

Multi-asset allocation views: Central banks’ delicate balancing act
6 Jun 2022
With high levels of inflation persisting around the world, central banks must tighten policy without hurting consumer demand and economic growth. This will be more difficult for some central banks than others, says Sunil Krishnan.
Read more

Our progress towards net zero in real assets: A Q&A with Ed Dixon
30 May 2022
One year on from publishing our 2040 net-zero pathway for real assets, Ed Dixon talks through some of the key highlights, challenges and priorities for 2022.
Read more

What does the data say? Where have the safe havens gone?
27 May 2022
In this month’s instalment of our visual series on topical themes, we look at how various asset classes are holding up in a turbulent year for financial markets.
Read more

Is stagflation set to make an unwanted return?
18 May 2022
Surging inflation is leading to fears the world economy could be heading towards recession. While there are diverging views on whether we are entering a new era of stagflation, the medium-term growth-inflation trade off looks set to worsen with big implication for asset prices, argue Michael Grady and Peter Fitzgerald.
Read more

Levelling up: Investing towards a new social contract
17 May 2022
As we learn to live with COVID-19, focus is returning to delivering a just transition. This is important to secure long-term investment outcomes, but also presents direct opportunities.
Read more

Conflict, commodities and China: The outlook for EMD
13 May 2022
Aaron Grehan and Nafez Zouk from our emerging market debt team explain how the asset class is standing up to some significant headwinds.
Read more

Life force: Why nature matters
12 May 2022
Growing awareness that natural systems are stressed or even close to breakdown is prompting asset managers to look closely at nature-based risks and investee companies to understand their environmental impacts and dependencies.
Read more